Abstract
The effects of two luteinizing hormone releasing hormone analogues (a superagonist and an antagonist) on the conversion of testosterone to dihydrotestosterone in homogenates prepared from adult rat ventral prostates were studied. At higher doses, the superagonist showed a significant dose-dependent inhibition of the conversion of testosterone to dihydrotestosterone. In comparison, the antagonist showed only a marginally inhibitory trend. The implications of these observed effects vis-a-vis the use of the analogues in the endocrine management of prostatic cancer have been discussed.
Similar content being viewed by others
Abbreviations
- LHRH:
-
Luteinizing hormone releasing hormone
- DHT:
-
dihydrotestosterone
References
Geller, J., Albert, J. and Loza, D. (1979)J. Steroid Biochem.,11, 631.
Geller, J., de La Vega, D. J., Albert, J. D. and Nachtshein, D. A. (1984)J. Clin. Endocrinol. Metab.,58, 36.
Joseph, R., Maitra, A., Moodbidri, S. A. and Sheth, A. R. (1987)Arch. Androl,18, 205.
Joseph, A. and Smith, J. R. (1987)J. Urol.,137, 1.
Massa, R. and Martini, L. (1974)J, Steroid Biochem.,5, 941.
Purvis, K., Brekke, I., Rui, H. and Sunde, A. (1986)J. Steroid Biochem.,25, 1023.
Sheth, A. R., Joseph, R. and Maitra, A. (1987a)Andrologie 19, 188.
Sheth, A. R., Joseph, R. and Maitra, A. (1987b)Indian J. Exp. Biol.,25, 503.
Trachtenberg, J. (1982)J. Urol.,128, 1097.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Maitra, A., Joseph, R., Sheth, A.R. et al. Effect of luteinizing hormone releasing hormone analogues on testosterone metabolismin vitro — A study with mature rat ventral prostates. J Biosci 13, 105–108 (1988). https://doi.org/10.1007/BF02903090
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02903090